DMK
CPRX icon

David M. Knott’s Catalyst Pharmaceutical CPRX Stock Holding History

David M. Knott’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-42,117
Closed -$195K – 99
2020
Q2 		$195K Sell
42,117
-11,000
-21% -$49.4K 0.11% 62
2020
Q1 		$205K Sell
53,117
-5,200
-9% -$21.3K 0.13% 73
2019
Q4 		$219K Sell
58,317
-93,098
-61% -$435K 0.09% 76
2019
Q3 		$804K Sell
151,415
-191,932
-56% -$1.02M 0.34% 50
2019
Q2 		$1.32M Sell
343,347
-167,500
-33% -$724K 0.56% 32
2019
Q1 		$2.6M Sell
510,847
-102,600
-17% -$302K 1.04% 22
2018
Q4 		$1.18M Buy
613,447
+59,972
+11% +$172K 0.55% 35
2018
Q3 		$2.09M Buy
553,475
+40,000
+8% +$125K 0.68% 28
2018
Q2 		$1.6M Buy
513,475
+24,900
+5% +$75.5K 0.6% 30
2018
Q1 		$1.17M Buy
488,575
+108,465
+29% +$360K 0.48% 28
2017
Q4 		$1.49M Buy
380,110
+15,000
+4% +$49.6K 0.59% 20
2017
Q3 		$920K Buy
365,110
+9,360
+3% +$25.7K 0.39% 25
2017
Q2 		$982K Buy
355,750
+71,400
+25% +$149K 0.41% 24
2017
Q1 		$554K Buy
+284,350
New +$362K 0.27% 32

Other funds holding CPRX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

David M. Knott's CPRX Position: Q3 2020 in Review

David M. Knott sold out of Catalyst Pharmaceutical (CPRX) in Q3 2020, closing a stake of 42,117 shares — an estimated $195K sold.

David M. Knott first reported a position in CPRX in Q1 2017 and held it in 14 quarters. The position peaked at $2.6M in Q1 2019. 142 funds tracked by Wall St. Rank hold CPRX as of Q3 2020.

  • David M. Knott reported no remaining Catalyst Pharmaceutical position as of Q3 2020 after selling out during the quarter.
  • David M. Knott sold 42,117 Catalyst Pharmaceutical shares in Q3 2020, an estimated $195K.
  • David M. Knott first reported a position in Catalyst Pharmaceutical in Q1 2017 and held it in 14 quarters.
  • David M. Knott's Catalyst Pharmaceutical position peaked at $2.6M in Q1 2019.
  • 142 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2020.

Based on David M. Knott's 13F filing for Q3 2020, filed 13 Nov 2020.